The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Updates on commercial insights and readiness plans for sozinibercept in wet AMD Opthea management to present in New York City on Tuesday, January 28 at 1:30 PM ET In-person events in Sydney on ...

Jedd Comiskey, Senior Vice President, Head of Europe, highlights the recent NICE recommendation of LYTENAVA™ (bevacizumab gamma) for the treatment of wet AMD Access the segment here ISELIN, N.J., Jan.

From redness to gradual loss of vision to constant irritation, here are the early warning signs of eye diseases that should ...

According to the American Kennel Club (AKC), vision loss in older dogs can stem from conditions like cataracts, glaucoma, ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Pravin U. Dugel, MD, Ocular’s Executive Chairman, President and CEO, will provide an update regarding the enrollment status of SOL-R, the Company’s second registrational trial of AXPAXLI™ for the ...

Aviceda Therapeutics has got biotech financing in 2025 off to a flying start by raising $207.5 million to take its lead drug ...

GA management involves identifying at-risk patients, assessing visual function, and referring for treatment when necessary.

Catch up on the clinical trial news, updates from the United States Food and Drug Administration (FDA), and company funding ...

Patients at Government Wenlock Hospital will now have access to cutting-edge ophthalmology diagnostics with the addition of ...